Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)
CNY 7.83
(2.89%)
CNY 7.83
(2.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 735.98 Million CNY | -22.29% |
| 2022 | 947.09 Million CNY | -10.6% |
| 2021 | 1.05 Billion CNY | 37.41% |
| 2020 | 770.96 Million CNY | -19.35% |
| 2019 | 955.95 Million CNY | 43.94% |
| 2018 | 664.12 Million CNY | 49.95% |
| 2017 | 442.9 Million CNY | -23.02% |
| 2016 | 575.35 Million CNY | 8.67% |
| 2015 | 529.44 Million CNY | 21.97% |
| 2014 | 434.07 Million CNY | 13.18% |
| 2013 | 383.51 Million CNY | 83.53% |
| 2012 | 208.97 Million CNY | 88.51% |
| 2011 | 110.85 Million CNY | 50.44% |
| 2010 | 73.69 Million CNY | 61.18% |
| 2009 | 45.72 Million CNY | 131.13% |
| 2008 | 19.78 Million CNY | 40.82% |
| 2007 | 14.04 Million CNY | 35.71% |
| 2006 | 10.35 Million CNY | 29.0% |
| 2005 | 8.02 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 229.94 Million CNY | 69.7% |
| 2024 Q1 | 135.5 Million CNY | 16.05% |
| 2024 Q3 | 122.57 Million CNY | -46.69% |
| 2023 Q2 | 297.89 Million CNY | 86.12% |
| 2023 Q1 | 160.05 Million CNY | -44.02% |
| 2023 Q4 | 116.76 Million CNY | -32.01% |
| 2023 Q3 | 171.74 Million CNY | -42.35% |
| 2023 FY | 735.98 Million CNY | -22.29% |
| 2022 Q3 | 418.07 Million CNY | 304.81% |
| 2022 FY | 947.09 Million CNY | -10.6% |
| 2022 Q4 | 285.9 Million CNY | -31.61% |
| 2022 Q2 | 103.27 Million CNY | -13.61% |
| 2022 Q1 | 119.54 Million CNY | -70.02% |
| 2021 Q4 | 398.78 Million CNY | 50.79% |
| 2021 Q3 | 264.46 Million CNY | 7.6% |
| 2021 FY | 1.05 Billion CNY | 37.41% |
| 2021 Q2 | 245.78 Million CNY | 125.82% |
| 2021 Q1 | 108.83 Million CNY | -64.82% |
| 2020 Q1 | 30.11 Million CNY | -92.16% |
| 2020 Q2 | 187.52 Million CNY | 522.67% |
| 2020 FY | 770.96 Million CNY | -19.35% |
| 2020 Q3 | 240.65 Million CNY | 28.33% |
| 2020 Q4 | 309.41 Million CNY | 28.57% |
| 2019 Q4 | 384.06 Million CNY | 75.96% |
| 2019 Q1 | 75 Million CNY | -63.53% |
| 2019 Q2 | 278.6 Million CNY | 271.45% |
| 2019 FY | 955.95 Million CNY | 43.94% |
| 2019 Q3 | 218.27 Million CNY | -21.66% |
| 2018 Q1 | 129.55 Million CNY | 33.08% |
| 2018 Q3 | 205.64 Million CNY | 58.73% |
| 2018 Q4 | 205.64 Million CNY | 0.0% |
| 2018 FY | 664.12 Million CNY | 49.95% |
| 2018 Q2 | 129.55 Million CNY | 0.0% |
| 2017 Q4 | 97.35 Million CNY | 0.0% |
| 2017 FY | 442.9 Million CNY | -23.02% |
| 2017 Q3 | 97.35 Million CNY | -21.56% |
| 2017 Q1 | 124.1 Million CNY | -29.72% |
| 2017 Q2 | 124.1 Million CNY | 0.0% |
| 2016 FY | 575.35 Million CNY | 8.67% |
| 2016 Q4 | 176.57 Million CNY | 0.0% |
| 2016 Q1 | 111.1 Million CNY | -33.22% |
| 2016 Q2 | 111.1 Million CNY | 0.0% |
| 2016 Q3 | 176.57 Million CNY | 58.93% |
| 2015 Q3 | 166.38 Million CNY | 69.19% |
| 2015 Q4 | 166.38 Million CNY | 0.0% |
| 2015 FY | 529.44 Million CNY | 21.97% |
| 2015 Q1 | 98.34 Million CNY | -32.85% |
| 2015 Q2 | 98.34 Million CNY | 0.0% |
| 2014 Q3 | 146.44 Million CNY | 107.46% |
| 2014 Q4 | 146.44 Million CNY | 0.0% |
| 2014 Q1 | 70.59 Million CNY | -49.86% |
| 2014 Q2 | 70.59 Million CNY | 0.0% |
| 2014 FY | 434.07 Million CNY | 13.18% |
| 2013 Q4 | 140.79 Million CNY | 43.58% |
| 2013 FY | 383.51 Million CNY | 83.53% |
| 2013 Q1 | 43.93 Million CNY | -51.07% |
| 2013 Q2 | 100.72 Million CNY | 129.25% |
| 2013 Q3 | 98.06 Million CNY | -2.64% |
| 2012 Q2 | 59.69 Million CNY | 254.52% |
| 2012 FY | 208.97 Million CNY | 88.51% |
| 2012 Q4 | 89.8 Million CNY | 110.64% |
| 2012 Q1 | 16.83 Million CNY | -68.64% |
| 2012 Q3 | 42.63 Million CNY | -28.58% |
| 2011 Q4 | 53.7 Million CNY | 85.47% |
| 2011 Q2 | 21.49 Million CNY | 220.44% |
| 2011 Q1 | 6.7 Million CNY | -78.7% |
| 2011 FY | 110.85 Million CNY | 50.44% |
| 2011 Q3 | 28.95 Million CNY | 34.72% |
| 2010 Q4 | 31.48 Million CNY | 119.65% |
| 2010 Q2 | 18.2 Million CNY | 88.4% |
| 2010 Q3 | 14.33 Million CNY | -21.24% |
| 2010 FY | 73.69 Million CNY | 61.18% |
| 2010 Q1 | 9.66 Million CNY | 0.0% |
| 2009 FY | 45.72 Million CNY | 131.13% |
| 2009 Q2 | 8.04 Million CNY | 0.0% |
| 2008 FY | 19.78 Million CNY | 40.82% |
| 2007 FY | 14.04 Million CNY | 35.71% |
| 2006 FY | 10.35 Million CNY | 29.0% |
| 2005 FY | 8.02 Million CNY | 0.0% |